Myrtace Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 31-07-2024
- Paid Up Capital ₹ 0.10 M
as on 31-07-2024
- Company Age 7 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 298.55%
(FY 2023)
- Profit 88.57%
(FY 2023)
- Ebitda 138.93%
(FY 2023)
- Net Worth -6.24%
(FY 2023)
- Total Assets 303.31%
(FY 2023)
About Myrtace Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Varadharajan Venkadasamy and Sakthivel Chinniah serve as directors at the Company.
- CIN/LLPIN
U85100TN2017PTC115518
- Company No.
115518
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Mar 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Myrtace Healthcare Private Limited offer?
Myrtace Healthcare Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, API Intermediate.
Who are the key members and board of directors at Myrtace Healthcare?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sakthivel Chinniah  | Managing Director | 16-May-2020 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Varadharajan Venkadasamy | Director | 17-Mar-2017 | Current |
Financial Performance of Myrtace Healthcare.
Myrtace Healthcare Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 298.55% increase. The company also saw a substantial improvement in profitability, with a 88.57% increase in profit. The company's net worth dipped by a decrease of 6.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Myrtace Healthcare?
In 2023, Myrtace Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Myrtace Healthcare?
Unlock and access historical data on people associated with Myrtace Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Myrtace Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Myrtace Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
